Suwon-si, South Korea

Seok Joon Won




Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seok Joon Won: Innovator in Neurodegenerative Disease Treatment

Introduction

Seok Joon Won is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. His innovative work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

Seok Joon Won holds a patent for "Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same." This invention relates to a tetrafluorobenzyl derivative and a pharmaceutical composition aimed at preventing and treating both acute and chronic neurodegenerative diseases, as well as ophthalmic diseases. The derivative can effectively be used to combat chronic neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, along with degenerative brain diseases like epilepsy and ischemic brain diseases such as stroke.

Career Highlights

Seok Joon Won is currently associated with Amkor Pharma, Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

He collaborates with notable colleagues, including Byoung Joo Gwag and Sung Hwa Yoon, to further enhance the research and development of effective treatments for neurodegenerative diseases.

Conclusion

Seok Joon Won's contributions to the field of pharmaceuticals, particularly in neurodegenerative disease treatment, highlight his role as an influential inventor. His innovative patent and ongoing work at Amkor Pharma, Inc. demonstrate his dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…